Plus   Neg

Teligent Inc. (TLGT) Has Climbed To A 5-Month High On FDA Approval

Teligent Inc. (TLGT) announced after the close Wednesday that it has received FDA approval for its Diflorasone Diacetate Ointment 0.05%.

Teligent has gapped open sharply higher Thursday morning and is now up 0.46 at $3.73 on above average volume. The stock has risen to a 5-month high.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT